亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A

作者
Christian Migliarese,Yinon Sadeh,Consuelo Torrini,Fatma Turna Demir,Naema Nayyar,Erika Yamazawa,Yuu Ishikawa,Nazanin Ijad,Elizabeth Summers,Adam Elliott,Lisa Rahbæk,Barbara Saechao,Jill F. Hallin,Priscilla Kaliopi Brastianos,Hiroaki Wakimoto
出处
期刊:Acta neuropathologica communications [Springer Science+Business Media]
卷期号:13 (1): 88-88 被引量:6
标识
DOI:10.1186/s40478-025-01993-2
摘要

KRAS mutations are prevalent in brain metastases (BM) from non-small cell lung cancer (NSCLC). The activity of KRAS-G12C selective, brain-penetrant small molecule inhibitor adagrasib was recently demonstrated in preclinical models of BM and patients with BM carrying KRAS-G12C, leading to a clinical trial investigating this therapeutic approach. However, co-existing genomic drivers such as homozygous deletion of CDKN2A/B may impact the utility of adagrasib. We therefore explored the combination therapy employing adagrasib and abemaciclib, a brain-penetrant CDK4/6 inhibitor, in NSCLC BM models driven by KRAS-G12C and CDKN2A loss. In both adagrasib-resistant SW1573 cells and adagrasib-responsive H2122 cells, combination of adagrasib and abemaciclib was slightly synergistic in inhibiting cell viability in vitro through targeting the KRAS-ERK and CDK4/6-Rb signaling pathways. Combination treatment was necessary to activate caspase 3/7-mediated apoptosis in SW1573 cells, while adagrasib alone and in combination comparably elicited apoptosis in H2122 cells. In vivo, combination treatment with adagrasib (75 mg/kg) twice daily and abemaciclib (50 mg/kg) daily was associated with body weight loss (about 10%) in mice bearing orthotopic BM derived with SW1573 or H2122 cells, requiring 50% dose reduction of adagrasib in some animals. Notably, combination treatment, but neither monotherapy, extended animal survival in the SW1573 model. On the other hand, adagrasib monotherapy and combination were similarly effective at prolonging survival, while abemaciclib monotherapy was ineffective in the H2122 model. Pharmacokinetic studies confirmed brain-penetrant properties of both agents and revealed drug-drug interactions as abemaciclib exposures in the plasma and brains were increased by the presence of adagrasib. Immunohistochemistry demonstrated on-target pharmacodynamic effects of both agents in BM in mice. Our work thus supports that the combination treatment of adagrasib and abemaciclib can offer a therapeutic strategy in NSCLC BM genomically characterized by KRAS-G12C and CDKN2A loss.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
激昂的慕山完成签到,获得积分10
11秒前
19秒前
隐形荟完成签到 ,获得积分10
24秒前
27秒前
舒适的夜柳完成签到,获得积分10
27秒前
kevin完成签到 ,获得积分10
36秒前
43秒前
orixero的应助被五岁的哈士奇采纳,获得10
44秒前
45秒前
YuxinChen完成签到 ,获得积分10
51秒前
快乐的稚晴完成签到,获得积分10
57秒前
1分钟前
小蘑菇的应助被科研通管家采纳,获得10
1分钟前
1分钟前
闪闪雍完成签到,获得积分10
1分钟前
2分钟前
健忘的小萱完成签到,获得积分10
2分钟前
玩命的芸遥完成签到,获得积分10
2分钟前
Andrew发布了新的文献求助10
2分钟前
Andrew完成签到,获得积分10
2分钟前
2分钟前
2分钟前
wanci的应助被五岁的哈士奇采纳,获得10
2分钟前
魔幻雪兰完成签到,获得积分10
2分钟前
奋斗的听露完成签到,获得积分10
3分钟前
霸气的似狮完成签到,获得积分10
3分钟前
听话的秋白完成签到,获得积分10
3分钟前
Hello的应助被YYY采纳,获得10
3分钟前
hupo完成签到,获得积分10
4分钟前
含蓄的雪冥完成签到,获得积分10
4分钟前
4分钟前
高高的仇血完成签到,获得积分10
4分钟前
朴实傲白完成签到 ,获得积分10
4分钟前
4分钟前
欢呼的兰完成签到,获得积分10
4分钟前
4分钟前
MT发布了新的文献求助10
4分钟前
soleil关注了科研通微信公众号
5分钟前
贪玩醉薇完成签到,获得积分10
5分钟前
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179920
求助须知:如何正确求助?哪些是违规求助? 9570103
关于积分的说明 21808354
捐赠科研通 7775701
什么是DOI,文献DOI怎么找? 3433193
关于科研通互助平台的介绍 2557347
邀请新用户注册赠送积分活动 2478918